Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 68 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9150588

    Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  2. US 9150500

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  3. US 9149475

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  4. US 9149489

    Inhibitors of glycolysis useful in the treatment of brain tumors

    The Board of Regents of the University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  5. US 9149479

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  6. TW 201536770

    Urea compounds and their use as enzyme inhibitors

    BIAL PORTELA & CA SA [PT] · Granted Oct 1, 2015 · Expires Sep 26, 2035

    granted
  7. US 9144605

    Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region

    The Board of Regents of the University of Texas System · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  8. US 9145433

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  9. US 9138437

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  10. US 9137973

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted
  11. US 9132174

    Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)

    Anchored RSK3 Inhibitors, LLC · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  12. US 9133200

    Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  13. US 9125922

    Phosphate esters of gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  14. US 9127021

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  15. US 9126956

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  16. US 9120758

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  17. US 9120747

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  18. US 9119837

    Use of sEH inhibitors as analgesics

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  19. US 9120744

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  20. US 9120790

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  21. US 9108934

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  22. US 9107956

    Oligomer-protease inhibitor conjugates

    Nektar Therapeutics · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  23. US 9095622

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  24. US 9096542

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted